SEC 13F Intelligence

Infinitum Asset Management, LLC / BNTC

Infinitum Asset Management, LLC’s Benitec Biopharma Inc Position

Does Infinitum Asset Management, LLC own Benitec Biopharma Inc (BNTC)? Yes — 923.0K shares worth $10M (+1.23% of its 13F portfolio) as of Q1 2026, up from 898.9K shares the prior filed quarter.

Position Value
$10M
Q1 2026
Shares
923.0K
% of Portfolio
+1.23%
Quarters Held
6
currently held

Position History BNTC

Reported value by quarter
Q4 ’24: $3MQ4 ’24Q1 ’25: $19MQ1 ’25Q2 ’25: $6MQ2 ’25Q3 ’25: $7MQ3 ’25Q4 ’25: $12MQ4 ’25Q1 ’26: $10MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026923.0K$10M+1.23%
Q4 2025898.9K$12M+1.79%
Q3 2025500.0K$7M+1.29%
Q2 2025500.0K$6M+1.30%
Q1 20251.13M$19M+6.05%
Q4 2024210.0K$3M+1.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Infinitum Asset Management, LLC’s full portfolio or all institutional holders of BNTC.